Acknowledgements Table of Contents About CIPHER CIPHER Paediatric Cohort Consultation Consultation Objectives...

Intira Jeannie Collins, Ruth Goodall, Colette Smith and Kara Wools-Kaloustian for the CIPHER Duration of First-Line Project Team.

Switch to second-line ART in HIV-infected children: a Collaborative Initiative for Paediatric HIV Education & Research (CIPHER) Global Cohort Collaboration analysis Intira Jeannie Collins, Ruth Goodall,

Analysis of the pre-art cascade among HIV-infected children aged 0-19 years in the IeDEA global network,

Analysis of the pre-art cascade among HIV-infected children aged 0-19 years in the IeDEA global network, 2004-2014 Sophie Desmonde 1, Frank Tanser 2, Rachel Vreeman 3, Elom Takassi 4, Andrew Edmonds 5,

Time to First-line ART Failure and Switch to Second-line ART in the IeDEA Pediatric Cohort

Time to First-line ART Failure and Switch to Second-line ART in the IeDEA Pediatric Cohort K. Wools-Kaloustian, S. Li, B. Musick, I. Marete, S. Ayaya, A. Sohn, L. Nguyen, V. Leroy, F. Eboua, J. Newman,

About Annette Sohn, MD. Biography

About Annette Sohn, MD Dr Annette Sohn is the Director of TREAT Asia, a regional programme of amfar, The Foundation for AIDS Research, in Bangkok, Thailand. TREAT Asia conducts a range of adult and paediatric

Prioritizing Paediatric HIV Annual Report 2014

Prioritizing Paediatric HIV Annual Report 2014 www.iasociety.org/cipher.aspx 2 The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Acknowledgements Project Team Marissa Vicari

Stunting and growth development for adolescents perinatally infected by HIV: males and females evolve differently.

Stunting and growth development for adolescents perinatally infected by HIV: males and females evolve differently. A multiregional analysis from the IeDEA global pediatric collaboration. Julie Jesson,

Dr Claire Townsend on behalf of EPPICC. Presented at the 2 nd International Workshop on HIV Pediatrics July 2010, Vienna Austria

Response to early antiretroviral treatment in HIV-infected infants: the experience of the European Pregnancy & Paediatric HIV Cohort Collaboration (EPPICC) Dr Claire Townsend on behalf of EPPICC Background

Programme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016

EVIDENCE TOACTION This session will highlight the essential role that collaborative research plays in improving public sector policies and services for HIV treatment and prevention. Across southern Africa

Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)

Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Ruth Goodall, Intira Jeannie Collins (MRC CTU at UCL), Luminita

Global research agendas for paediatric & adolescent HIV

Global research agendas for paediatric & adolescent HIV Marissa Vicari, Alice Armstrong, Cadi Irvine, Diddie Schaaf and Martina Penazzato Policy briefs Paediatric and Adolescent briefs In English and French

Virologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study.

Virologic Outcomes of HIV-Infected Children Undergoing a Single-Class Drug Substitution from LPV/r- to EFV-Based cart: A retrospective cohort study. K. Reichmuth 1, J. Nuttall, H. Rabie, B. Eley, H. Moultrie,

High-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd

Adolescent transition to adult care: what do we know and research priorities High-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd Outline 1. What is transition? 2. Who is

Lessons learned from the IeDEA West Africa Collaboration

Lessons learned from the IeDEA West Africa Collaboration François DABIS with the contribution of Didier Koumavi EKOUEVI INSERM U-897, Bordeaux, France, Programme PACCI, ANRS site, Abidjan, Côte d Ivoire

Acquired HIV Drug Resistance in children in Asia

Acquired HIV Drug Resistance in children in Asia Jintanat Ananworanich, MD, PhD Pediatrician/Immunologist Deputy Director in Scientific Affairs, HIV-NAT Chief, SEARCH The Thai Red Cross AIDS Research Centre

Scaling up priority HIV/AIDS interventions in the health sector

TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

Modelling Paediatric HIV and the Need for Antiretroviral Therapy: October 2017

Modelling Paediatric HIV and the Need for Antiretroviral Therapy: October 2017 Report and Recommendations from a hosted by WHO and UNAIDS in collaboration with the UNAIDS Reference Group on Estimates,

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings

Impact of the frequency of plasma viral load monitoring on treatment outcome among perinatally HIVinfected Asian children stable on first-line NNRTI-based cart T Sudjaritruk, DC Boettiger, NV Lam, KAM

OUTCOMES OF INFANTS STARTING ANTIRETROVIRAL THERAPY IN SOUTHERN AFRICA,

OUTCOMES OF INFANTS STARTING ANTIRETROVIRAL THERAPY IN SOUTHERN AFRICA, 2004-2012 Mireille Porter 1 *, Mary-ann Davies 1, Muntanga K. Mapani 2, Helena Rabie 3, Sam Phiri 4, James Nuttall 5, Lee Fairlie

Creating a broader-based response to treatment failure and HIV drug resistance

Creating a broader-based response to treatment failure and HIV drug resistance Addy Chen Coordinator, MSM+ Working Group Asia Pacific Network of People Living with HIV/AIDS (APN+) Treatment Failure in

Primer on Simulation Modeling: Using Model-Based Analyses to Inform Health Policy and Research on HIV Prevention

Primer on Simulation Modeling: Using Model-Based Analyses to Inform Health Policy and Research on HIV Prevention Caitlin Dugdale, MD Massachusetts General Hospital Global HIV Vaccine Enterprise Modeling

State of the Network. TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008

State of the Network TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008 Research Community Education TAHOD Program Update Current recruitment of ~4,000 patients from 17 sites in 12 countries

No adolescent living with HIV left behind: a coalition for action

May 2014 No adolescent living with HIV left behind: a coalition for action Participating organisations Asia Pacific Network of People Living with HIV African Young Positives CIPHER, International AIDS

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS

AIDS by the Numbers: Where Do We Stand with 90-90-90? Peter Ghys, UNAIDS ACHIEVING THE 90 90 90 TARGETS, 2016 FIGURE 3.2. COUNTRIES THAT HAVE ACHIEVED THE 90 90 90 TARGETS OR ARE NEAR TO ACHIEVING THEM,

Program to control HIV/AIDS

90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

CD4 Assays Are No Longer Needed for Care of Children in Low-resource Countries. The case against Di Gibb

CD4 Assays Are No Longer Needed for Care of Children in Low-resource Countries The case against Di Gibb The value of CD4 Pre-ART CD4 CD4 monitoring on ART Pre-ART CD4 for linkage to care & clinical management

9 th INTERNATIONAL WORKSHOP ON HIV PEDIATRICS PARIS, FRANCE 21-22 JULY 2017 SPONSORSHIP REQUEST 2017 www.virology-education.com INTRODUCTION & SIGNIFICANCE Support our efforts and establish your reputation

Mapping and Building Consensus on Research Priorities for Women and Children

Mapping and Building Consensus on Research Priorities for Women and Children Shirin Heidari, Ph.D. International AIDS Society 8 December 2009, Geneva WHO/UNAIDS Informal Consultation with Pharmaceutical

Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT)

Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT) Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies

Ethico-legal challenges in conducting HIV prevention trial research with adolescents: a South African case study of tool development

Ethico-legal challenges in conducting HIV prevention trial research with adolescents: a South African case study of tool development Melissa Wallace 1, Ann Strode 2, Cathy Slack 2, Agnes Ronan 1 and Linda-Gail

From to zero new infections, zero deaths, reduced stigma

From 95-95-95 to zero new infections, zero deaths, reduced stigma Ambassador Deborah Birx IAS July 2018 #PEPFAR15 Moving from generic to specific Moving from words to action Holding ourselves accountable

Improving accessibility to antiretroviral drugs: A south-south collaboration

Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected

Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.

F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected

Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand

Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand Rachel C. Vreeman, MD, MS Director of Research, IU Center for Global Health Associate Professor of Pediatrics Indiana University

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa. Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya

Current challenges of paediatric HIV care Experiences in Sub-Saharan Africa Dr. Elizabeth Obimbo University of Nairobi Nairobi, Kenya Current Challenges of Paediatric HIV Care What is Happening in the

Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST. Graeme Meintjes University of Cape Town

Efavirenz vs dolutegravir for 1st line ART: Is it time to change? The argument AGAINST Graeme Meintjes University of Cape Town Benefits of dolutegravir Superior efficacy in SINGLE trial Side effect profile

18 July 2009 The 1st International Workshop on HIV Pediatrics Cape Town, South Africa

A Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC), Nevirapine (NVP): Pharmacokinetics and Safety in HIV-Infected Thai Children 18 July 2009 The 1st International Workshop

Number of people receiving ARV therapy in developing and transitional countries by region,

Progress in numbers The last six months have seen dramatic progress toward the 3 by 5 target. Between June and, the number of people receiving antiretroviral (ARV) therapy in developing and transitional

Pediatric HIV/AIDS training course February 23-25, 2013

Pediatric HIV/AIDS training course February 23-25, 2013 St. Jude Children s Research Hospital Memphis, TN Dear Delegate, The American Academy of Pediatrics and the Committee on Pediatric AIDS are delighted

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of

Progress against the HIV Epidemic: is the end in sight?

Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

Challenges along the paediatric ARV pipeline Summary: IAS-ILF Industry Roundtable on Paediatric ARVs. Presented by Shaffiq Essajee (CHAI, USA)

Challenges along the paediatric ARV pipeline Summary: IAS-ILF Industry Roundtable on Paediatric ARVs Presented by Shaffiq Essajee (CHAI, USA) Optimize paediatric ARVs and shape the market PADO New drugs,

Oral microbiota in relation to HIV infection and oral infection in perinatally HIV-infected adolescents

Oral microbiota in relation to HIV infection and oral infection in perinatally HIV-infected adolescents Bruce J. Paster Jacqueline R. Starr Kyu Ha Lee Lina Faller Barbara Moscicki Russell Van Dyke Mark

HIV/AIDS in East Asia

HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women

All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis. Against the motion

All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis Against the motion Hermione Lyall Imperial Healthcare NHS Trust, London, UK Acknowledgements: Pat Tookey, Ali Judd, Claire

Mary-Ann Davies and Matthias Egger on behalf of the IeDEA-SA Collaboration

Mary-Ann Davies and Matthias Egger on behalf of the IeDEA-SA Collaboration www.iedea-sa.org National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child

The Impact of the Global Economic Crisis on HIV and AIDS. Carlos Avila. 7 December 2009 UNAIDS Geneva

The Impact of the Global Economic Crisis on HIV and AIDS Carlos Avila 7 December 2009 UNAIDS Geneva Outline 1. What the monitoring system is telling us? 2. What are the driving forces? 3. What countries

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

Pediatric Antiretroviral Therapy

Update on Pediatric Antiretroviral Therapy Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch National Institute of Child Health and Human Development National Institutes of Health

IAPAC 11 th International Conference on HIV Treatment and Prevention Adherence Fort Lauderdale, FL May 11, 2016

Nonadherence and Unsuppressed Viral Load Across Stages of Adolescent Development in US Youth with Perinatally Acquired HIV in the Pediatric HIV/AIDS Cohort Study: A Longitudinal Analysis Deborah Kacanek,

The European network for paediatric research. Carlo Giaquinto University of Padova Padova

The European network for paediatric research Carlo Giaquinto University of Padova Padova Types of Paediatric networks (examples) Clinical Trials networks: National networks (MCRN, FinPedMed, CICPed, PaedNet

Ending the AIDS Epidemic in Adolescents

Ending the AIDS Epidemic in Adolescents Eastern and Southern Africa Regional Update on the ALL IN Overview 13 October 2015 AIDS-related deaths has declined for all age groups Except adolescents! Eastern

Attrition and Treatment Outcomes among Perinatally and Behaviourally HIV-infected Adolescents and Youths in Thai National AIDS program

Attrition and Treatment Outcomes among Perinatally and Behaviourally HIV-infected Adolescents and Youths in Thai National AIDS program Sirinya Teeraananchai 1,2, Thanyawee Puthanakit 1,3,4, Suchada Chaivooth

Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum

Medical Challenges of HIV/AIDS pandemic: The WHO perspective SOLTHIS HIV Forum Marco Vitoria HIV/AIDS Department World Health Organization September 2013 Topic 2002 2003 2006 2010 2013 When to start 1

Concept note. 1. Background and rationale

Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL

Assessment of G8 Commitments on Maternal, Newborn and Child Health

Assessment of G8 Commitments on Maternal, Newborn and Child Health Robin Lennox Researcher, G8 Research Group June 13, 2010 In January 2010, Canadian prime minister Stephen Harper announced that maternal,

GLOBAL STATISTICS FACT SHEET 2015

FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with

Lopinavir Hair Concentrations Predict Virological Failure Among Asian Children

Lopinavir Hair Concentrations Predict Virological Failure Among Asian Children Wasana Prasitsuebsai, Stephen J. Kerr, Truong Huu Khanh, Jintanat Ananworanich, Do Chau Viet, Nguyen Van Lam, Nia Kurniati,

Barriers to Papanicolaou Screening among HIV-Infected Women: a cross sectional survey

Barriers to Papanicolaou Screening among HIV-Infected Women: a cross sectional survey Arya Payan M.S., B.S. Touro University, Nevada University of Nevada School of Medicine HealthySunrise Foundation Saman

Downloaded from:

Fitzgerald, FC; Bekker, LG; Kaplan, R; Myer, L; Lawn, SD; Wood, R (2010) Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. South African Medical Journal, 100

GLOBAL HIV STATISTICS

F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model Background for the program development Problem areas Access to the whole HIV-care

The outlook for hundreds of thousands adolescents is bleak.

Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds

MEETING PROSPECTUS CHALLENGES & SOLUTIONS INTERNATIONAL WORKSHOP ON HIV ADOLESCENCE CAPE TOWN, SOUTH AFRICA OCTOBER 2018

INTERNATIONAL WORKSHOP ON HIV ADOLESCENCE CHALLENGES & SOLUTIONS CAPE TOWN, SOUTH AFRICA 10-12 OCTOBER 2018 MEETING PROSPECTUS WELCOME Dear Colleague, We are proud to announce the 2nd International Workshop

Revisiting Optimal Breast Feeding Durations: Modelling the impact of maternal ARV use and infant mortality

Revisiting Optimal Breast Feeding Durations: Modelling the impact of maternal ARV use and infant mortality Divya Mallampati, MD, MPH Rachel MacLean Andrea Ciaranello, MD, MPH World Health Organization

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017

ICTMM 21 Sept 2016 Mark Boyd Chair of Medicine/Professorial Fellow University of Adelaide/UNSW University of Adelaide 2 1 University of Adelaide 3 Myanmar BASIC SOCIO-DEMOGRAPHIC INDICATORS Total population

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 90-90-90 1 Ensure that 30 million people living with HIV have access to treatment through meeting the 90 90 90 targets

Latest Funding Trends in AIDS Response

Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July

Childhood Vaccination and Immunisation

DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &

Towards universal access

Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

Antiretroviral Therapy Cohort Collaboration

Antiretroviral Therapy Cohort Collaboration http://www.bristol.ac.uk/art-cc/research/presentations/ 2015 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, USA, February 2015 Margaret

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv

The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people

Efficacy, Safety, and Adherence of TDF/3TC/EFV Once Daily in Virologic-suppressed HIV-infected Children following Switching from NNRTI-based Regimens

O_05 Efficacy, Safety, and Adherence of TDF/3TC/EFV Once Daily in Virologic-suppressed HIV-infected Children following Switching from NNRTI-based Regimens Linda Aurpibul MD. 1, Thition Narkbunnam MD. 2,

East Carolina University Continuing Education Courses for Sustainability Symposium

East Carolina University Continuing Education Courses for 2016-17 2017 Sustainability Symposium Sustainability has emerged as a primary concern for many sectors, including academic institutions and industries

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

Section C Global Burden Global Smoking Prevalence Source: adapted by CTLT from The Tobacco Atlas. (2006). 2 1 Cigarette Consumption in China (1952 1996) Average Number of Manufactured Cigarettes Smoked

BMC Infectious Diseases

BMC Infectious Diseases This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Identification of

New Directions on WHO ARV Guidelines 2018

New Directions on WHO ARV Guidelines 2018 Elaine Abrams Co-chair WHO Guidelines Development Group ICAP at Columbia University, New York Martina Penazzato Paediatric lead for the HIV Department World Health

S P. Optimizing HIV/AIDS prevention programs: towards multidimensional allocative efficiency. Sergio Bautista Paola Gadsden Stefano M Bertozzi

ASAP Regional Training on Epidemiological and Economic Tools for HIV/AIDS Strategic Planning S P Optimizing HIV/AIDS prevention programs: towards multidimensional allocative efficiency Sergio Bautista

SPONSORSHIP REQUEST 2017 www.virology-education.com INTRODUCTION & SIGNIFICANCE Support our efforts and establish your reputation in HIV Pediatrics. With this document, we would like to request your financial

HIV Treatment Update. Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University

HIV Treatment Update Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University Outline Rationale for highly active antiretroviral therapy (HAART) When to start

Preliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi

Preliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi Spencer Nundwe 1, Oren Jalon 2, Reinaldo Ortuno 2, Carol Metcalf 3, Sarah Daho 1, Helen Bygrave 3, Michael Murowa 4, Kingsley

Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings

CLINICAL SCIENCE Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings Diana Huis in t Veld, MD,* Eric Balestre, MPH, k Jozefien Buyze,

Has HIV Treatment Guideline Expansion Improved the Timely Uptake of ART?

Has HIV Treatment Guideline Expansion Improved the Timely Uptake of ART? Denis Nash, PhD, MPH City University of New York (CUNY) Executive Director, CUNY Institute of Implementation Science in Population

Health outcomes & research objectives in (crosscultural)international

Health outcomes & research objectives in (crosscultural)international research Brian Oldenburg Professor of International Public Health & Associate Dean (Global Health and International Campuses) brian.oldenburg@monash.edu

HIV drug resistance and tracing outcomes among antiretroviral therapy defaulters in Malawi

HIV drug resistance and tracing outcomes among antiretroviral therapy defaulters in Malawi Bello G 1, ParkinN 2, KagoliM 1, ChipetaS 1, CzaickiN 3, Pry J 3, OdenyT 3, NyasuluI 4, LapointeH 5, Doherty M

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Epidemiology of HIV in Adolescent & Young Women Lynne M. Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide

Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors

Response to early antiretroviral therapy in HIV-1 infected infants in Europe,

Europe PMC Funders Group Author Manuscript Published in final edited form as: AIDS. 2011 November 28; 25(18): 2279 2287. doi:10.1097/qad.0b013e32834d614c. Response to early antiretroviral therapy in HIV-1

Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network:

Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network: Pregnant Women in the NIAID HIV/AIDS Clinical Trials Network Recompetition Carl W. Dieffenbach, Ph.D. Director Division

Strategic Plan. Briefing. Strategic Plan Annual Results. Briefing. Associate Director, Nutrition 15 June 2015 Danny Kaye. Associate Director

2014 2014 Strategic Plan Strategic Plan Annual Annual Results Results Briefing Briefing Nutrition Werner Werner Schultink Schultink Associate Director Associate Director, 15 June 2015 Nutrition 15 June

SPONSORSHIP OPPORTUNITIES

CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd International Conference on Obesity & Chronic Diseases March 14-15, 2019 Bali, Indonesia our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme

TB epidemic and progress towards the Millennium Development Goals

Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

A Call to Action Children The missing face of AIDS

A Call to Action Children The missing face of AIDS Prevention of Mother to Child Transmission: Implementation Status in Asia and Pacific Dr Myo Zin Nyunt, UNICEF ROSA CONSULTATION ON INTEGRATING PREVENTION

Addressing Global Reproductive Health Challenges

Addressing Global Reproductive Health Challenges Amb. Dr. Eunice Brookman-Amissah, MB.ChB, FWACP, FRCOG Vice President for Africa, Ipas United Nations Commission on Population and Development 13 April